Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.

Piatek CI, Bocian H, Algaze S, Weitz IC, O Apos Connell C, Liebman HA.

Acta Haematol. 2019 Oct 30:1-6. doi: 10.1159/000501538. [Epub ahead of print]

PMID:
31665725
2.

Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells.

Benguigui M, Weitz IS, Timaner M, Kan T, Shechter D, Perlman O, Sivan S, Raviv Z, Azhari H, Shaked Y.

Sci Rep. 2019 Aug 30;9(1):12613. doi: 10.1038/s41598-019-48959-8.

3.

Thrombotic Microangiopathy in Cancer.

Weitz IC.

Semin Thromb Hemost. 2019 Jun;45(4):348-353. doi: 10.1055/s-0039-1687893. Epub 2019 Apr 30.

PMID:
31041804
4.

Sensation Seeking and Impulsivity Can Increase Exposure to Risky Media and Moderate Its Effects on Adolescent Risk Behaviors.

Khurana A, Bleakley A, Ellithorpe ME, Hennessy M, Jamieson PE, Weitz I.

Prev Sci. 2019 Jul;20(5):776-787. doi: 10.1007/s11121-019-0984-z.

PMID:
30659453
5.

Do you see what I see? A character analysis of health risk behaviors in television shows popular with Black adolescents in the US.

Bleakley A, Ellithorpe ME, Prince L, Hennessy M, Khurana A, Jamieson PE, Weitz I.

J Child Media. 2018;12(4):478-495. doi: 10.1080/17482798.2018.1487310. Epub 2018 Jul 9.

6.

Media violence exposure and aggression in adolescents: A risk and resilience perspective.

Khurana A, Bleakley A, Ellithorpe ME, Hennessy M, Jamieson PE, Weitz I.

Aggress Behav. 2019 Jan;45(1):70-81. doi: 10.1002/ab.21798. Epub 2018 Sep 23.

PMID:
30246419
7.

Complement-mediated thrombotic microangiopathy associated with lupus nephritis.

Park MH, Caselman N, Ulmer S, Weitz IC.

Blood Adv. 2018 Aug 28;2(16):2090-2094. doi: 10.1182/bloodadvances.2018019596.

8.

Thrombotic microangiopathy in cancer.

Weitz IC.

Thromb Res. 2018 Apr;164 Suppl 1:S103-S105. doi: 10.1016/j.thromres.2018.01.014. Epub 2018 Jan 9. Review.

PMID:
29703465
9.

Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical center.

O'Neill CM, Weitz IC, O'Connell C, Liebman HA.

Platelets. 2019;30(3):413-417. doi: 10.1080/09537104.2018.1453061. Epub 2018 Mar 26.

PMID:
29580123
10.

Copper oxide loaded PLGA nanospheres: towards a multifunctional nanoscale platform for ultrasound-based imaging and therapy.

Perlman O, Weitz IS, Sivan SS, Abu-Khalla H, Benguigui M, Shaked Y, Azhari H.

Nanotechnology. 2018 May 4;29(18):185102. doi: 10.1088/1361-6528/aab00c. Epub 2018 Feb 16.

PMID:
29451124
11.

Risky movies, risky behaviors, and ethnic identity among Black adolescents.

Bleakley A, Ellithorpe ME, Hennessy M, Jamieson PE, Khurana A, Weitz I.

Soc Sci Med. 2017 Dec;195:131-137. doi: 10.1016/j.socscimed.2017.10.024. Epub 2017 Nov 13.

12.

Target visualisation and microwave hyperthermia monitoring using nanoparticle-enhanced transmission ultrasound (NETUS).

Perlman O, Weitz IS, Azhari H.

Int J Hyperthermia. 2018 Sep;34(6):773-785. doi: 10.1080/02656736.2017.1378386. Epub 2017 Oct 24.

PMID:
29063825
13.

Effective treatment of chemotherapy induced atypical Haemolytic Uraemic Syndrome: a case series of 7 treated patients.

Weitz IC, Deloughery T.

Br J Haematol. 2018 Oct;183(1):136-139. doi: 10.1111/bjh.14910. Epub 2017 Aug 31. No abstract available.

PMID:
28857126
14.

Differences in the Portrayal of Health Risk Behaviors by Black and White Characters in Popular Films.

Ellithorpe ME, Bleakley A, Hennessy M, Weitz I, Jamieson P, Khurana A.

J Health Commun. 2017 Jun;22(6):451-458. doi: 10.1080/10810730.2017.1290165. Epub 2017 May 8.

15.

Alcohol, Sex, and Screens: Modeling Media Influence on Adolescent Alcohol and Sex Co-Occurrence.

Bleakley A, Ellithorpe ME, Hennessy M, Khurana A, Jamieson P, Weitz I.

J Sex Res. 2017 Oct;54(8):1026-1037. doi: 10.1080/00224499.2017.1279585. Epub 2017 Feb 26.

16.

Autoimmune Hemolytic Anemia.

Liebman HA, Weitz IC.

Med Clin North Am. 2017 Mar;101(2):351-359. doi: 10.1016/j.mcna.2016.09.007. Epub 2016 Dec 14. Review.

PMID:
28189175
17.

OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin.

Piatek CI, Tagawa ST, Wei-Tsai D, Hanna D, Weitz IC, O'Connell C, Rochanda L, Groshen S, Liebman HA.

Thromb Res. 2016 Apr;140 Suppl 1:S174. doi: 10.1016/S0049-3848(16)30131-1. Epub 2016 Apr 8.

PMID:
27161687
18.

Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.

Kelly RJ, Höchsmann B, Szer J, Kulasekararaj A, de Guibert S, Röth A, Weitz IC, Armstrong E, Risitano AM, Patriquin CJ, Terriou L, Muus P, Hill A, Turner MP, Schrezenmeier H, Peffault de Latour R.

N Engl J Med. 2015 Sep 10;373(11):1032-9. doi: 10.1056/NEJMoa1502950.

19.

Copper oxide nanoparticles as contrast agents for MRI and ultrasound dual-modality imaging.

Perlman O, Weitz IS, Azhari H.

Phys Med Biol. 2015 Aug 7;60(15):5767-83. doi: 10.1088/0031-9155/60/15/5767. Epub 2015 Jul 10.

PMID:
26159685
20.

Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.

Boonyasampant M, Weitz IC, Kay B, Boonchalermvichian C, Liebman HA, Shulman IA.

Transfusion. 2015 Oct;55(10):2398-403. doi: 10.1111/trf.13144. Epub 2015 May 18.

PMID:
25989361
21.

Atypical hemolytic uremic syndrome: the role of complement pathway gene mutation analysis.

Weitz IC.

Clin Adv Hematol Oncol. 2014 Apr;12(4):266-8. No abstract available.

PMID:
25003358
22.

Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia.

Aldoss I, Mark L, Vrona J, Ramezani L, Weitz I, Mohrbacher AM, Douer D.

Ann Hematol. 2014 Nov;93(11):1839-43. doi: 10.1007/s00277-014-2124-y. Epub 2014 Jun 7.

PMID:
24906216
23.

Complement the hemostatic system: an intimate relationship.

Weitz IC.

Thromb Res. 2014 May;133 Suppl 2:S117-21. doi: 10.1016/S0049-3848(14)50020-5. Review.

PMID:
24862131
24.

Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.

Chaudhary P, Hepgur M, Sarkissian S, Smith RJ, Weitz IC.

Blood Transfus. 2014 Jan;12(1):111-3. doi: 10.2450/2013.0107-13. Epub 2013 Nov 15. No abstract available.

25.

A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.

Raza A, Ravandi F, Rastogi A, Bubis J, Lim SH, Weitz I, Castro-Malaspina H, Galili N, Jawde RA, Illingworth A.

Cytometry B Clin Cytom. 2014 May;86(3):175-82. doi: 10.1002/cyto.b.21139. Epub 2013 Nov 12.

26.

Gun violence trends in movies.

Bushman BJ, Jamieson PE, Weitz I, Romer D.

Pediatrics. 2013 Dec;132(6):1014-8. doi: 10.1542/peds.2013-1600. Epub 2013 Nov 11.

PMID:
24218475
27.

A Prospective Multicenter Study of Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure.

Raza A, Ravandi F, Rastogi A, Bubis J, Lim SH, Weitz I, Castro-Malaspina H, Galili N, Jawde RA, Illingworth A.

Cytometry B Clin Cytom. 2013 Oct 11. doi: 10.1002/cytob.21139. [Epub ahead of print]

28.

Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.

Szer J, Hill A, Weitz IC.

Clin Adv Hematol Oncol. 2012 Nov;10(11 Suppl 21):1-16.

PMID:
23271156
29.

Cross-sectional validation study of patient-reported outcomes in patients with paroxysmal nocturnal haemoglobinuria.

Weitz I, Meyers G, Lamy T, Cahn JY, Uranga MT, García Vela JA, Sanz MA, Severino B, Kelly RJ, Hillmen P, Hill A.

Intern Med J. 2013 Mar;43(3):298-307. doi: 10.1111/j.1445-5994.2012.02924.x.

PMID:
22909078
30.

Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation.

Weitz IC, Razavi P, Rochanda L, Zwicker J, Furie B, Manly D, Mackman N, Green R, Liebman HA.

Thromb Res. 2012 Sep;130(3):361-8. doi: 10.1016/j.thromres.2012.04.001. Epub 2012 Apr 28.

PMID:
22542362
31.

A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia.

Weitz I, Sanz MA, Henry D, Schipperus M, Godeau B, Northridge K, Gleeson M, Danese M, Deuson R.

Curr Med Res Opin. 2012 May;28(5):789-96. doi: 10.1185/03007995.2012.684046. Epub 2012 Apr 25.

PMID:
22494019
32.

Thrombosis in patients with paroxysmal nocturnal hemoglobinuria.

Weitz IC.

Semin Thromb Hemost. 2011 Apr;37(3):315-21. doi: 10.1055/s-0031-1273095. Epub 2011 Mar 31.

PMID:
21455865
33.

Thrombosis in Paroxysmal Nocturnal Hemoglobinuria - insights into the role of complement in thrombosis.

Weitz IC.

Thromb Res. 2010 Apr;125 Suppl 2:S106-7. doi: 10.1016/S0049-3848(10)70026-8. No abstract available.

PMID:
20433987
34.

Immune thrombocytopenia in patients with connective tissue disorders and the antiphospholipid antibody syndrome.

Arkfeld DG, Weitz IC.

Hematol Oncol Clin North Am. 2009 Dec;23(6):1239-49. doi: 10.1016/j.hoc.2009.08.010. Review.

PMID:
19932431
35.

The role of oral anticoagulants in tumor biology.

Weitz IC, Liebman HA.

Semin Thromb Hemost. 2007 Oct;33(7):695-8. Review.

PMID:
18000797
36.

Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis.

Oliveira B, Arkfeld DG, Weitz IC, Shinada S, Ehresmann G.

J Clin Rheumatol. 2007 Apr;13(2):89-91.

PMID:
17414538
38.

Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.

Sutherland DE, Weitz IC, Liebman HA.

Am J Hematol. 2003 Jan;72(1):43-52. Review.

39.

Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study.

Presant CA, Jacobson J, Wolf W, Waluch V, Weitz IC, Macdonald JS; Southwest Oncology Group.

Invest New Drugs. 2002 Nov;20(4):369-76.

PMID:
12448653
40.

Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.

Weitz IC, Israel VK, Waisman JR, Presant CA, Rochanda L, Liebman HA.

Thromb Haemost. 2002 Aug;88(2):213-20.

PMID:
12195692
42.

Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.

Weitz IC, Israel VK, Liebman HA.

Cancer. 1997 May 15;79(10):2024-7.

PMID:
9149031
43.

Synthesis of a Trisubstituted 1,4-Diazepin-3-one-Based Dipeptidomimetic as a Novel Molecular Scaffold.

Weitz IS, Pellegrini M, Mierke DF, Chorev M.

J Org Chem. 1997 Apr 18;62(8):2527-2534.

PMID:
11671593
44.

Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.

Weitz IC, Liebman HA.

Hepatology. 1993 Oct;18(4):990-7. Review.

PMID:
8406374
45.

Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase.

Liebman HA, Carfagno MK, Weitz IC, Berard P, Diiorio JM, Vosburgh E, Simms RW.

Am J Clin Pathol. 1992 Nov;98(5):534-41.

PMID:
1485607
46.

Bone scan-positive and radiograph- and CT-negative vertebral lesion in a woman with locally advanced breast cancer.

Mink JH, Weitz I, Kagan AR, Steckel RJ.

AJR Am J Roentgenol. 1987 Feb;148(2):341-3. No abstract available.

PMID:
3026158

Supplemental Content

Support Center